Estimating the microvascular benefits of screening type 2 diabetes mellitus

International Journal of Technology Assessment in Health Care

Volumn 16, Issue 3, 2000, Pages 822-833

  Hofer, T P ^a   Vijan, S ^a   Hayward, R A ^a  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

Diabetes mellitus; Mass screening; Models; Non insulin dependent; Prevention and control; Statistical

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; BLINDNESS; COST BENEFIT ANALYSIS; DIABETES CONTROL; DIABETIC RETINOPATHY; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HUMAN; MASS SCREENING; MICROVASCULATURE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; STATISTICAL MODEL;

EID: 0033800905     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0266462300102090     Document Type: Article

References (29)

1. Veterans Affair Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility trial
2. Screening for type 2 diabetes
3. The cost-effectiveness of screening for type 2 diabetes. CDC Diabetes Cost-Effectiveness Study Group, Centers for Disease Control and Prevention
4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
5. The relationship of glycemic exposure (HBA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial
6. Incidence of diabetic retinopathy and blindness: A population-based study in Rochester, Minnesota
7. Screening for diabetes mellitus in adults: The utility of random capillary blood glucose measurements
8. Early detection of undiagnosed non-insulin-dependent diabetes mellitus
9. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994
10. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis
11. The costs and effectiveness of insulin therapy: Results from the type II diabetes PORT
12. A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes
13. Healthy behaviors among women in the United States and Ontario: The effect on use of preventive care
14. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group
15. Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population
16. Relation of ocular and systemic factors to survival in diabetes
17. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes, VII: Mortality and selected nonfatal events with insulin treatment
18. Ten-year incidence of visual loss in a diabetic population
19. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
20. A clinical approach for the diagnosis of diabetes mellitus: An analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels
21. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus
22. Performance of an NIDDM screening questionnaire based on symptoms and risk factors
23. Diabetes should be caught earlier, experts say; stricter blood sugar standards, widespread screening of adults over 45 recommended
24. Taking aim at diabetes; Centers for Disease Control and Prevention urge increased screening
25. United Kingdom Prospective Diabetes Study 17: A 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus
26. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes